Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALFACALCIDOL Cause Malignant neoplasm progression? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with ALFACALCIDOL. This represents 0.6% of all adverse event reports for ALFACALCIDOL.

5
Reports of Malignant neoplasm progression with ALFACALCIDOL
0.6%
of all ALFACALCIDOL reports
4
Deaths
4
Hospitalizations

How Dangerous Is Malignant neoplasm progression From ALFACALCIDOL?

Of the 5 reports, 4 (80.0%) resulted in death, 4 (80.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALFACALCIDOL. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ALFACALCIDOL Cause?

Off label use (145) Maternal exposure during pregnancy (120) Headache (118) Pyrexia (118) Lower respiratory tract infection (114) Condition aggravated (109) Fatigue (101) Folliculitis (101) Dyspnoea (97) Hypersensitivity (95)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which ALFACALCIDOL Alternatives Have Lower Malignant neoplasm progression Risk?

ALFACALCIDOL vs ALFENTANIL ALFACALCIDOL vs ALFUZOSIN ALFACALCIDOL vs ALGLUCOSIDASE ALFA ALFACALCIDOL vs ALIMTA ALFACALCIDOL vs ALIROCUMAB

Related Pages

ALFACALCIDOL Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression ALFACALCIDOL Demographics